Table 3 Adjusted HRs for type 2 diabetes according to breast cancer status stratified by age
From: Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancer
Breast cancer | ||||
---|---|---|---|---|
Control | Breast cancer | Without using tamoxifen | Using tamoxifen | |
Age | Adjusted HR (95% CI) | Adjusted HR (95% CI) | Adjusted HR (95% CI) | |
Model 1 | ||||
20–54 | 1.00 | 1.18 (1.10–1.25)*** | 1.07 (0.95–1.20) | 1.22 (1.13–1.31)*** |
⩾55 | 1.00 | 1.12 (1.04–1.21)** | 1.03 (0.90–1.17) | 1.16 (1.06–1.26)*** |
Model 2 | ||||
20–54 | 1.00 | 1.31 (1.15–1.50)*** | ||
⩾55 | 1.00 | 1.37 (1.17–1.59)*** |